Edition:
India

Nabriva Therapeutics PLC (NBRV.OQ)

NBRV.OQ on NASDAQ Stock Exchange Global Select Market

3.01USD
22 Mar 2019
Change (% chg)

$-0.14 (-4.44%)
Prev Close
$3.15
Open
$3.15
Day's High
$3.15
Day's Low
$2.90
Volume
150,867
Avg. Vol
101,232
52-wk High
$6.01
52-wk Low
$1.13

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.80 -0.460
Sep '18 0.46 -0.904
Jun '18 0.85 -0.439
Mar '18 7.55 -0.361
FY 2017 Dec '17 1.12 -0.605
Sep '17 1.47 -0.791
Jun '17 1.05 -0.537
Mar '17 1.68 -5.596
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 3 0.61 1.00 0.34 1.40
Quarter Ending Jun-19 3 0.86 1.07 0.50 2.60
Year Ending Dec-19 8 15.07 30.40 6.56 15.97
Year Ending Dec-20 8 39.46 68.75 23.00 58.94
Earnings (per share)
Quarter Ending Mar-19 4 -0.34 -0.31 -0.36 -0.62
Quarter Ending Jun-19 4 -0.33 -0.30 -0.35 0.96
Year Ending Dec-19 8 -1.22 -0.73 -1.45 -2.04
Year Ending Dec-20 8 -0.84 -0.52 -1.25 -1.32
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 72.07 -- --
EPS (TTM) % -7.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nabriva Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.25 -8.52 47 --
13 Week -20.95 -24.80 37 --
26 Week -24.27 -30.03 54 --
52 Week 15.92 -1.75 99 --
YTD 39.26 22.30 99 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 53.17%
# of Holders: 56
Total Shares Held: 37,059,141
3 Mo. Net Change: -2,096,563
# New Positions: 14
# Closed Positions: 14
# Increased Positions: 21
# Reduced Positions: 30
# Net Buyers: -9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.